Live Breaking News & Updates on Leukotriene Receptor Antagonist Montelukast

Stay updated with breaking news from Leukotriene receptor antagonist montelukast. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

IntelGenx Announces First Parkinson's Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 'MONTPARK' Clinical Trial -April 08, 2024 at 07:45 am EDT

SAINT LAURENT, Quebec, April 08, 2024 IntelGenx Corp. today announced that Montelukast VersaFilm® has been administered to the first Parkinson’s Disease patients in the Phase 2 clinical. ....

United States , Saint Laurent , Dwight Gorham , Stephen Kilmer , Andre Godin , Montelukast Versafilm , Exchange Commission , Intelgenx Corp , Drug Administration , Swedish University , Intelgenx Technologies Corp , World Health Organization , Parkinson Foundation , Securities Exchange , Karolinska University Hospital , Company Or Intelgenx , Per Svenningsson , Lead Principal , Health Organization , Leukotriene Receptor Antagonist Montelukast , Looking Information , Securities Exchange Act , Securities Act , United States Securities , Intelgenx Technologies ,

IntelGenx Announces First Parkinson's Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ?MONTPARK' Clinical Trial

IntelGenx Announces First Parkinson's Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ?MONTPARK' Clinical Trial
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Saint Laurent , United States , Montelukast Versafilm , Stephen Kilmer , Andre Godin , Dwight Gorham , Intelgenx Technologies Corp , Company Or Intelgenx , Intelgenx Corp , Exchange Commission , Swedish University , Parkinson Foundation , Karolinska University Hospital , World Health Organization , Securities Exchange , Drug Administration , Genx Announces First Parkinson , Disease Patients Dosed , Per Svenningsson , Lead Principal , Health Organization , Leukotriene Receptor Antagonist Montelukast , Looking Information , Securities Exchange Act , Securities Act , United States Securities ,

IntelGenx Receives Approval to Conduct 'MONTPARK' Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson's Disease

IntelGenx Receives Approval to Conduct 'MONTPARK' Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson's Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Saint Laurent , Stephen Kilmer , Intelgenx Montelukast Versafilm , Dwight Gorham , Andre Godin , Montelukast Versafilm , Intelgenx Corp , Swedish University , Swedish Research Council , Intelgenx Technologies Corp , Exchange Commission , Regional Biobank Centre , Swedish Ethical Review Authority , Company Or Intelgenx , Securities Exchange , World Health Organization , Karolinska University Hospital , Swedish Medical Products Agency , Parkinson Foundation , Per Svenningsson , Swedish Crowns , Intelgenx Montelukast , Health Organization , Leukotriene Receptor Antagonist Montelukast , Looking Information ,